| Literature DB >> 32147375 |
Le Luo1, Jing Chen1, Xiaomin Li1, Dan Qiao1, Zhenyu Wang1, Xingchen Wu1, Qian Du1, Dewen Tong2, Yong Huang3.
Abstract
Transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) are the main pathogens causing viral diarrhea in pig, mixed infections of these two viruses are very common in intensive pig rearing. However, there is a lack of a method to simultaneously detect and distinguish PEDV and TGEV in preclinical levels. In this study, we aimed to establish a dual ultrasensitive nanoparticle DNA probe-based PCR assay (dual UNDP-PCR) based on functionalized magnetic bead enrichment and specific nano-technology amplification for simultaneous detection and distinguish diagnosis of PEDV and TGEV. The detection limit of dual UNDP-PCR for single or multiple infections of PEDV and TGEV is 25 copies/g, which is 400 times more sensitive than the currently known duplex RT-PCR, showing better specificity and sensitivity without cross-reaction with other viruses. For pre-clinical fecal samples, the dual UNDP-PCR showed a markedly higher positive detection rate (52.08%) than conventional duplex RT-PCR (13.21%), can rapidly and accurately identify targeted pathogens whenever simple virus infection or co-infection. In summary, this study provides a technique for detecting and distinguishing PEDV and TGEV in preclinical levels, which is high sensitivity, specificity, repeatability, low cost and broad application prospect.Entities:
Keywords: Co-infection; Dual ultrasensitive detection; Porcine epidemic diarrhea virus; Preclinical diagnosis; Transmissible gastroenteritis virus
Mesh:
Substances:
Year: 2020 PMID: 32147375 PMCID: PMC7128872 DOI: 10.1016/j.jiac.2020.01.008
Source DB: PubMed Journal: J Infect Chemother ISSN: 1341-321X Impact factor: 2.211
Fig. 1Analysis of the sensitivity of dual UNDP-PCR for PEDV and TGEV. (A) Serial dilutions of PEDV and TGEV fecal samples were tested by dual UNDP-PCR assay. M: Trans 2K Plus DNA Marker; other lanes represent different viral concentration of fecal samples were detected by UNDP-PCR assay. 103:103 copies/g; 102: 102 copies/g; 50: 50 copies/g; 25: 25 copies/g; 20: 20 copies/g; 15: 15 copies/g; 10: 10 copies/g; 0: negative samples. (B) Serial dilutions of PEDV and TGEV fecal samples were tested by duplex RT-PCR assay. M: Trans 2K Plus DNA Marker; other lanes are the viral concentration of fecal samples. 105:105 copies/g; 104: 104 copies/g; 5000: 5000 copies/g; 2500: 2500 copies/g; 1250: 1250 copies/g; 0: negative samples.
Fig. 2Analysis of the reproducibility and specificity of dual UNDP-PCR for PEDV and TGEV. (A)Three repeated test of each concentration in three independent assays for three consecutive days were detected by dual UNDP-PCR for PEDV and TGEV. M: Trans 2K Plus DNA Marker; other lanes are the viral concentration of fecal samples. 104: 104 copies/g; 103: 103 copies/g; 102: 102 copies/g; -: negative samples. (B)Samples infected with PPV, PRV, PCV2, CSFV, PRRSV and healthy samples were detected by dual UNDP-PCR for PEDV and TGEV as control. M:Trans 2K Plus DNA Marker; other lanes indicate samples contained with different viruses or healthy samples, among them “Others” represents the sample contained with PPV, PRV, PCV2, CSFV and PRRSV.
Comparison of the detection results of 272 fecal samples collected tested by dual UNDP-PCR and conventional duplex RT-PCR.
| Assay | Stage | Number of each component | Rate of each component (%) | Total number of tested samples |
|---|---|---|---|---|
| dual UNDP-PCR | pre-clinical positive | 50 | 18.38 | 272 |
| clinical positive | 46 | 16.91 | ||
| Negative | 176 | 64.71 | ||
| duplex RT-PCR | pre-clinical positive | 7 | 2.57 | 272 |
| clinical positive | 46 | 16.91 | ||
| Negative | 219 | 80.52 |